Literature DB >> 9737941

Beta-tropomyosin overexpression induces severe cardiac abnormalities.

M Muthuchamy1, G P Boivin, I L Grupp, D F Wieczorek.   

Abstract

Tropomyosin, a coiled-coil dimer, stabilizes actin filaments and is central to the control of calcium-regulated striated muscle contraction. Striated muscle-specific alpha-tropomyosin is the predominant isoform in cardiac muscle, with low levels of beta-tropomyosin restricted to fetal development in the mouse. To understand the functional role of various tropomyosin isoforms during myofilament activation and regulation in the intact sarcomere, we generated transgenic mice that overexpress striated muscle-specific beta-tropomyosin in the adult heart. Our earlier results succinctly demonstrate that overexpression of beta-tropomyosin in the hearts of transgenic mice decreases endogeneous alpha-tropomyosin levels while altering diastolic function of the myocardium. To explore further the significance of altering the alpha- to beta-tropomyosin isoform ratio in developing murine myocardium, we generated transgenic mice which express beta-tropomyosin at high levels in the heart. The data show that higher levels of beta-tropomyosin expression are lethal with death ensuing between 10-14 days postnatally. A detailed histological analysis demonstrates that the hearts of these mice exhibit several pathological abnormalities, including thrombus formation in the lumen of both atria and in the subendocardium of the left ventricle. Other changes include atrial enlargement and fibrosis, and diffuse myocytolysis, Physiological analyses using ventricular muscle strip preparations from these mice reveal that both myocardial contraction and relaxation parameters are severely impaired. Thus, these results firmly demonstrate an essential difference in tropomyosin isoform function in physiologically regulating cardiac performance. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737941     DOI: 10.1006/jmcc.1998.0720

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  19 in total

Review 1.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Statistically enhanced spectral counting approach to TCDD cardiac toxicity in the adult zebrafish heart.

Authors:  Jiang Zhang; Kevin A Lanham; Warren Heideman; Richard E Peterson; Lingjun Li
Journal:  J Proteome Res       Date:  2013-06-12       Impact factor: 4.466

3.  In vitro formation and characterization of the skeletal muscle α·β tropomyosin heterodimers.

Authors:  Athanasia Kalyva; Anja Schmidtmann; Michael A Geeves
Journal:  Biochemistry       Date:  2012-08-03       Impact factor: 3.162

4.  Repression of the Central Splicing Regulator RBFox2 Is Functionally Linked to Pressure Overload-Induced Heart Failure.

Authors:  Chaoliang Wei; Jinsong Qiu; Yu Zhou; Yuanchao Xue; Jing Hu; Kunfu Ouyang; Indroneal Banerjee; Caimei Zhang; Biyi Chen; Hairi Li; Ju Chen; Long-Sheng Song; Xiang-Dong Fu
Journal:  Cell Rep       Date:  2015-03-05       Impact factor: 9.423

5.  Charged residue alterations in the inner-core domain and carboxy-terminus of alpha-tropomyosin differentially affect mouse cardiac muscle contractility.

Authors:  Robert D Gaffin; Carl W Tong; David C Zawieja; Timothy E Hewett; Raisa Klevitsky; Jeffrey Robbins; Mariappan Muthuchamy
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

6.  Top-down targeted proteomics for deep sequencing of tropomyosin isoforms.

Authors:  Ying Peng; Xin Chen; Han Zhang; Qingge Xu; Timothy A Hacker; Ying Ge
Journal:  J Proteome Res       Date:  2012-12-20       Impact factor: 4.466

Review 7.  Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse.

Authors:  Brian R Berridge; Vasanthi Mowat; Hirofumi Nagai; Abraham Nyska; Yoshimasa Okazaki; Peter J Clements; Matthias Rinke; Paul W Snyder; Michael C Boyle; Monique Y Wells
Journal:  J Toxicol Pathol       Date:  2016-07-29       Impact factor: 1.628

8.  RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player.

Authors:  K Häbig; M Walter; S Poths; O Riess; M Bonin
Journal:  Neurogenetics       Date:  2007-12-21       Impact factor: 2.660

9.  Charged residue changes in the carboxy-terminus of alpha-tropomyosin alter mouse cardiac muscle contractility.

Authors:  Robert D Gaffin; Kuppan Gokulan; James C Sacchettini; Timothy Hewett; Raisa Klevitsky; Jeffrey Robbins; Mariappan Muthuchamy
Journal:  J Physiol       Date:  2004-02-06       Impact factor: 5.182

10.  Myofibril-inducing RNA (MIR) is essential for tropomyosin expression and myofibrillogenesis in axolotl hearts.

Authors:  Chi Zhang; Pingping Jia; Xupei Huang; Gian Franco Sferrazza; Gagani Athauda; Mohan P Achary; Jikui Wang; Sharon L Lemanski; Dipak K Dube; Larry F Lemanski
Journal:  J Biomed Sci       Date:  2009-09-03       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.